TYK2 and colorectal carcinoma: In this study, we showed the decreased expression of TYK2 at the protein level in neoplastic cells compared with normal intestinal epithelium and epithelial cells from inflamed colons, which underlines the potential value of TYK2 in monitoring CRC progression.